PubRank

Maureen Rischmueller

Author PubWeight™ 24.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sleep disordered breathing in patients with primary Sjögren's syndrome: a group controlled study. Sleep Med 2012 2.07
2 Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet 2013 1.79
3 Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Arthritis Rheum 2012 1.20
4 Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome. Arthritis Rheum 2006 1.06
5 Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Semin Arthritis Rheum 2007 1.02
6 Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis. Arthritis Res Ther 2012 0.96
7 Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome. Ann Rheum Dis 2010 0.91
8 Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study. Arthritis Res Ther 2008 0.91
9 Immunolocalization of NLRP3 Inflammasome in Normal Murine Airway Epithelium and Changes following Induction of Ovalbumin-Induced Airway Inflammation. J Allergy (Cairo) 2012 0.90
10 Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome. PLoS One 2011 0.89
11 Low copy number of the Fc-γ receptor 3B gene FCGR3B is a risk factor for primary Sjogren's syndrome. J Rheumatol 2012 0.89
12 Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome. J Rheumatol 2003 0.87
13 Upper airway surface tension but not upper airway collapsibility is elevated in primary Sjögren's syndrome. Sleep 2008 0.85
14 Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study. J Rheumatol 2011 0.85
15 Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome. Hum Immunol 2005 0.83
16 The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Res Ther 2013 0.83
17 Fc-Gamma Receptor 3B Copy Number Variation Is Not a Risk Factor for Behçet's Disease. Int J Rheumatol 2012 0.81
18 Risk of cancer in patients with biopsy-proven giant cell arteritis. Rheumatology (Oxford) 2010 0.80
19 Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndrome. Arthritis Res Ther 2013 0.80
20 Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. J Clin Rheumatol 2010 0.79
21 An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3. Arthritis Res Ther 2014 0.79
22 TLR4 polymorphism is not associated with biopsy proven giant cell arteritis. Clin Exp Rheumatol 2014 0.76
23 CTLA4 polymorphism and primary Sjögren's syndrome. Arthritis Res Ther 2007 0.76
24 Susceptibility for Lupus Nephritis by Low Copy Number of the FCGR3B Gene Is Linked to Increased Levels of Pathogenic Autoantibodies. Autoimmune Dis 2013 0.76
25 No evidence of an association between the interleukin-10 promoter GCC allele and primary Sjögren's syndrome: comment on the article by Hulkkonen et al. Arthritis Rheum 2002 0.75
26 Response to: the interaction of Sjogren's syndrome, gastroesophageal reflux and sleep by Tufik et al. Sleep Med 2012 0.75
27 No Association between FC γ R3B Copy Number Variation and Susceptibility to Biopsy-Proven Giant Cell Arteritis. Arthritis 2013 0.75
28 The use of temporal artery ultrasound in the diagnosis of giant cell arteritis in routine practice. Int J Rheum Dis 2013 0.75
29 Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome. Arthritis Rheum 2003 0.75
30 No Zinc Deficiency But a Putative Immunosuppressive Role for Labile Zn in Patients with Systemic Autoimmune Disease. Curr Rheumatol Rev 2017 0.75